These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31657651)

  • 1. Cefpirome Treatment Results in Limited Selection of Stable Derepressed
    Gautam V; Mouton JW; Ten Kate MT; Bakker-Woudenberg IAJM; van Burgh S; Strepis N; Klaassen CHW; Goessens W
    Microb Drug Resist; 2020 Apr; 26(4):341-348. PubMed ID: 31657651
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection.
    Goessens WH; Mouton JW; ten Kate MT; Bijl AJ; Ott A; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2007 Mar; 59(3):507-16. PubMed ID: 17289765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.
    Barnaud G; Labia R; Raskine L; Sanson-Le Pors MJ; Philippon A; Arlet G
    FEMS Microbiol Lett; 2001 Feb; 195(2):185-90. PubMed ID: 11179650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant gram-negative bacteria.
    Piddock LJ; Traynor EA
    J Antimicrob Chemother; 1991 Aug; 28(2):209-19. PubMed ID: 1778852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo activities of Syn2190, a novel beta-lactamase inhibitor.
    Nishida K; Kunugita C; Uji T; Higashitani F; Hyodo A; Unemi N; Maiti SN; Phillips OA; Spevak P; Atchison KP; Salama SM; Atwal H; Micetich RG
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1895-900. PubMed ID: 10428909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of mutants with resistance or diminished susceptibility to ceftazidime/avibactam from ESBL- and AmpC-producing Enterobacteriaceae.
    Livermore DM; Mushtaq S; Doumith M; Jamrozy D; Nichols WW; Woodford N
    J Antimicrob Chemother; 2018 Dec; 73(12):3336-3345. PubMed ID: 30247546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What does the susceptible-dose dependent interpretive category for cefepime in ESBL-producing bacteria?
    Menegucci TC; Bastos MS; Viana GF; Moreira RRB; Garcia LB; Cardoso CL; Tognim MCB
    J Chemother; 2017 Jun; 29(3):189-194. PubMed ID: 27077929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacodynamics of avibactam in combination with ceftaroline or ceftazidime against β-lactamase-producing Enterobacteriaceae studied in an in vitro model of infection.
    MacGowan A; Tomaselli S; Noel A; Bowker K
    J Antimicrob Chemother; 2017 Mar; 72(3):762-769. PubMed ID: 28039276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae.
    Binfiglio G; Stefani S; Nicoletti G
    Chemotherapy; 1994; 40(5):311-6. PubMed ID: 7956454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne
    Shields RK; Chen L; Cheng S; Chavda KD; Press EG; Snyder A; Pandey R; Doi Y; Kreiswirth BN; Nguyen MH; Clancy CJ
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal infections with multidrug-resistant ESBL-producing E. cloacae and K. pneumoniae in Neonatal Units of two different Hospitals in Antananarivo, Madagascar.
    Naas T; Cuzon G; Robinson AL; Andrianirina Z; Imbert P; Ratsima E; Ranosiarisoa ZN; Nordmann P; Raymond J
    BMC Infect Dis; 2016 Jun; 16():275. PubMed ID: 27287441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic resistance in Enterobacter cloacae strains with derepressed/partly derepressed/inducible AmpC and extendedspectrum beta-lactamases in Zenica-Doboj Canton, Bosnia and Herzegovina.
    Uzunović S; Ibrahimagić A; Bedenić B
    Med Glas (Zenica); 2018 Feb; 15(1):37-45. PubMed ID: 29214986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics of β-lactamase inhibition by NXL104 in combination with ceftaroline: examining organisms with multiple types of β-lactamases.
    Louie A; Castanheira M; Liu W; Grasso C; Jones RN; Williams G; Critchley I; Thye D; Brown D; Vanscoy B; Kulawy R; Drusano GL
    Antimicrob Agents Chemother; 2012 Jan; 56(1):258-70. PubMed ID: 22024819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducing capacity and selection of resistant variants of cefpirome (HR 810) in comparison with other beta-lactam compounds.
    Stobberingh EE; Houben AW
    Chemotherapy; 1988; 34(6):490-6. PubMed ID: 3072153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
    Zhang Y; Wang Q; Yin Y; Chen H; Jin L; Gu B; Xie L; Yang C; Ma X; Li H; Li W; Zhang X; Liao K; Man S; Wang S; Wen H; Li B; Guo Z; Tian J; Pei F; Liu L; Zhang L; Zou C; Hu T; Cai J; Yang H; Huang J; Jia X; Huang W; Cao B; Wang H
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
    Martínez-Beltrán J; Cantón R; Liñares J; García de Lomas J; Gimeno C; Tubau F; Baquero F
    Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):244-52. PubMed ID: 7614970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins.
    Fung-Tomc JC; Gradelski E; Huczko E; Dougherty TJ; Kessler RE; Bonner DP
    Antimicrob Agents Chemother; 1996 May; 40(5):1289-93. PubMed ID: 8723487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility patterns to extended-spectrum cephalosporins among Enterobacteriaceae harbouring extended-spectrum β-lactamases using the updated Clinical and Laboratory Standards Institute interpretive criteria.
    Kristo I; Pitiriga V; Poulou A; Zarkotou O; Kimouli M; Pournaras S; Tsakris A
    Int J Antimicrob Agents; 2013 Apr; 41(4):383-7. PubMed ID: 23375981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
    Mohanty S; Gaind R; Ranjan R; Deb M
    J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supporting the ceftaroline fosamil/avibactam Enterobacteriaceae breakpoint determination using humanised in vivo exposures in a thigh model.
    Bhalodi AA; Crandon JL; Williams G; Nicolau DP
    Int J Antimicrob Agents; 2014 Dec; 44(6):508-13. PubMed ID: 25278330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.